{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:12:36Z","timestamp":1789902756834,"version":"4.0.1"},"reference-count":118,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The role of nitric oxide (NO), soluble guanylate cyclase (sGC), and the cyclic guanosine monophosphate (cGMP) pathway in cardiovascular and renal health and disease is a complex issue. The impact of these biochemical pathways on the vascular tree is well established: the activation of sGC by NO promotes vasodilation and modulates vascular tone. Indeed, additional characteristics exist that lead physicians to believe there is a pleiotropic influence of this pathway on the functional activities and structural characteristics of human tissues and cells. Recently, sGC stimulators have demonstrated clinical efficacy in patients with worsening heart failure with reduced ejection fraction, improving cardiovascular death risk, re-hospitalization for HF, and all-cause mortality. These new outcome data have increased interest in understanding the potential pathophysiological mechanisms. The NO-sGC-cGMP axis may influence endothelial function, kidney performance, and cardiac muscle cell activity. The synergy of these actions could explain the positive effects of vericiguat on worsening HF. The aim of this narrative review was to provide a comprehensive insight into the pathophysiological mechanisms of action of NO-sGC-cGMP axis stimulators on cardiac muscle, endothelial cells, and kidneys.<\/jats:p>","DOI":"10.3390\/ijms26104550","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T09:56:19Z","timestamp":1746784579000},"page":"4550","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Influence of Soluble Guanylate Cyclase on Cardiac, Vascular, and Renal Structure and Function: A Physiopathological Insight"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1055-0973","authenticated-orcid":false,"given":"Daniele","family":"De Feo","sequence":"first","affiliation":[{"name":"Cardiology Section, University of Bari, 70121 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Massari","sequence":"additional","affiliation":[{"name":"Cardiology Section, Hospital \u201cF. Perinei\u201d Altamura (BA), 70022 Altamura, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosimo","family":"Campanella","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital \u201cSan Paolo\u201d Bari, 70132 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Livrieri","sequence":"additional","affiliation":[{"name":"Cardiology Section, University of Bari, 70121 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Matteo","family":"Ciccone","sequence":"additional","affiliation":[{"name":"Cardiology Section, University of Bari, 70121 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Caldarola","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital \u201cSan Paolo\u201d Bari, 70132 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micaela","family":"De Palo","sequence":"additional","affiliation":[{"name":"Cardiac Surgery Section, University of Bari, 70121 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0471-0053","authenticated-orcid":false,"given":"Pietro","family":"Scicchitano","sequence":"additional","affiliation":[{"name":"Cardiology Section, Hospital \u201cF. Perinei\u201d Altamura (BA), 70022 Altamura, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"ref_1","unstructured":"(2024, December 09). The Nobel Prize in Physiology or Medicine 1998. NobelPrize.org. Nobel Prize Outreach 2025. Available online: https:\/\/www.nobelprize.org\/prizes\/medicine\/1998\/summary\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/CIRCULATIONAHA.110.981738","article-title":"Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease","volume":"123","author":"Stasch","year":"2011","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.biopha.2017.10.122","article-title":"Nitric oxide bioavailability dysfunction involves in atherosclerosis","volume":"97","author":"Chen","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1177\/0003319720979243","article-title":"Novel Insights Regarding Nitric Oxide and Cardiovascular Diseases","volume":"72","author":"Infante","year":"2021","journal-title":"Angiology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.rmed.2016.08.022","article-title":"Anti-fibrotic effects of soluble guanylate cyclase stimulators and activators: A review of the preclinical evidence","volume":"122","author":"Sandner","year":"2017","journal-title":"Respir. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e004813","DOI":"10.1161\/CIRCHEARTFAILURE.118.004813","article-title":"Exploring New Cardiovascular Pathways: Are Soluble Guanylate Cyclase Stimulators the Right Direction?","volume":"11","author":"Michalak","year":"2018","journal-title":"Circ. Heart Fail."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1111\/bph.15500","article-title":"Visualising and understanding cGMP signals in the cardiovascular system","volume":"179","author":"Feil","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"ref_8","first-page":"CD005151","article-title":"Nitrates for acute heart failure syndromes","volume":"8","author":"Wakai","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ijcard.2014.01.102","article-title":"PDE5 inhibitor sildenafil in the treatment of heart failure: A meta-analysis of randomized controlled trials","volume":"172","author":"Zhuang","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"ref_10","first-page":"CD002230","article-title":"Phosphodiesterase III inhibitors for heart failure","volume":"1","author":"Amsallem","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s11255-015-1071-4","article-title":"Phosphodiesterase type 5 inhibitors and kidney disease","volume":"47","author":"Afsar","year":"2015","journal-title":"Int. Urol. Nephrol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Gansevoort, R.T., Wheeler, D.C., Deb\u00e9n, F.M., Speeckaert, M., Thomas, D., Berger, M., Klein, S., Friedrichs, F., Paraschin, K., and Schmieder, R.E. (Nephrol. Dial. Transplant, 2024). The soluble guanylate cyclase activator runcaciguat significantly improves albuminuria in patients with chronic kidney disease: A randomized placebo-controlled clinical trial, Nephrol. Dial. Transplant, (Online ahead of print).","DOI":"10.1093\/ndt\/gfae261"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.coph.2014.12.014","article-title":"Renal effects of soluble guanylate cyclase stimulators and activators: A review of the preclinical evidence","volume":"21","author":"Stasch","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.cellsig.2011.09.001","article-title":"Guanylyl cyclase structure, function and regulation","volume":"23","author":"Potter","year":"2011","journal-title":"Cell Signal."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2174\/092986707780059715","article-title":"Cardiovascular cGMP-generating systems in physiological and pathological conditions","volume":"14","author":"Cerra","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1080\/14656566.2021.1937121","article-title":"Vericiguat for the treatment of heart failure: Mechanism of action and pharmacological properties compared with other emerging therapeutic options","volume":"22","author":"Hulot","year":"2021","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/FJC.0000000000000802","article-title":"Cardiac cGMP Signaling in Health and Disease: Location, Location, Location","volume":"75","author":"Cuello","year":"2020","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1242\/jcs.113.10.1671","article-title":"Rising behind NO: cGMP-dependent protein kinases","volume":"113","author":"Hofmann","year":"2000","journal-title":"J. Cell. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/FJC.0000000000000817","article-title":"Targets of cGMP\/cGKI in Cardiac Myocytes","volume":"75","author":"Adler","year":"2020","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00015.2005","article-title":"Function of cGMP-dependent protein kinases as revealed by gene deletion","volume":"86","author":"Hofmann","year":"2006","journal-title":"Physiol. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00395-018-0690-1","article-title":"A concise discussion of the regulatory role of cGMP kinase I in cardiac physiology and pathology","volume":"113","author":"Hofmann","year":"2018","journal-title":"Basic Res. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"37429","DOI":"10.1074\/jbc.274.52.37429","article-title":"A novel interaction of cGMP-dependent protein kinase I with troponin T","volume":"274","author":"Yuasa","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/CIRCRESAHA.108.184408","article-title":"Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs","volume":"104","author":"Lang","year":"2009","journal-title":"Circ. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1113\/jphysiol.2001.014126","article-title":"Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes","volume":"540","author":"Layland","year":"2002","journal-title":"J. Physiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1161\/01.RES.84.9.1020","article-title":"Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes","volume":"84","author":"Younes","year":"1999","journal-title":"Circ. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/CIRCHEARTFAILURE.115.002308","article-title":"Molecular Screen Identifies Cardiac Myosin-Binding Protein-C as a Protein Kinase G-I\u03b1 Substrate","volume":"8","author":"Thoonen","year":"2015","journal-title":"Circ. Heart Fail."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00424-013-1396-8","article-title":"Cardiac myosin binding protein-C as a central target of cardiac sarcomere signaling: A special mini review series","volume":"466","author":"Sadayappan","year":"2014","journal-title":"Pflug. Arch."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.yjmcc.2009.11.014","article-title":"Phosphorylation and function of cardiac myosin binding protein-C in health and disease","volume":"48","author":"Barefield","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.yjmcc.2010.09.007","article-title":"Analysis of cardiac myosin binding protein-C phosphorylation in human heart muscle","volume":"49","author":"Copeland","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.yjmcc.2007.05.003","article-title":"Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure","volume":"43","author":"Pohlmann","year":"2007","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Pedriali, G., Ramaccini, D., Bouhamida, E., Wieckowski, M.R., Giorgi, C., Tremoli, E., and Pinton, P. (2022). Perspectives on mitochondrial relevance in cardiac ischemia\/reperfusion injury. Front. Cell. Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.1082095"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"H468","DOI":"10.1152\/ajpheart.00360.2003","article-title":"Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection","volume":"286","author":"Oldenburg","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"H874","DOI":"10.1152\/ajpheart.01189.2007","article-title":"Intramitochondrial signaling: Interactions among mitoKATP, PKCepsilon, ROS, and MPT","volume":"295","author":"Costa","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.yjmcc.2007.10.006","article-title":"Essential role of mitochondrial Ca2+-activated and ATP-sensitive K+ channels in sildenafil-induced late cardioprotection","volume":"44","author":"Wang","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1161\/CIRCRESAHA.107.156976","article-title":"Protein kinase G phosphorylates Cav1.2 \u03b11c and \u03b22 subunits","volume":"101","author":"Yang","year":"2007","journal-title":"Circ. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0008-6363(03)00546-7","article-title":"Single L-type Ca2+ channel regulation by cGMP-dependent protein kinase type I in adult cardiomyocytes from PKG I transgenic mice","volume":"60","author":"Klein","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.yjmcc.2017.01.013","article-title":"Mechanisms of the cyclic nucleotide cross-talk signaling network in cardiac L-type calcium channel regulation","volume":"106","author":"Zhao","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.crphys.2022.03.004","article-title":"Regulation of cardiac ryanodine receptor function by the cyclic-GMP dependent protein kinase G","volume":"5","author":"Gonano","year":"2022","journal-title":"Curr. Res. Physiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.yjmcc.2012.03.015","article-title":"PKA phosphorylation of cardiac ryanodine receptor modulates SR luminal Ca2+ sensitivity","volume":"53","author":"Ullrich","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"30256","DOI":"10.1074\/jbc.M703510200","article-title":"Functional consequence of protein kinase A-dependent phosphorylation of the cardiac ryanodine receptor: Sensitization of store overload-induced Ca2+ release","volume":"282","author":"Xiao","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_42","first-page":"923","article-title":"Regulation of sarcoplasmic reticulum protein phosphorylation by localized cyclic GMP-dependent protein kinase in vascular smooth muscle cells","volume":"40","author":"Cornwell","year":"1991","journal-title":"Mol. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/bbrc.1995.2258","article-title":"Cyclic GMP-mediated phospholamban phosphorylation in intact cardiomyocytes","volume":"214","author":"Sabine","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1093\/cvr\/cvz311","article-title":"Nitric oxide modulates cardiomyocyte pH control through a biphasic effect on sodium\/hydrogen exchanger-1","volume":"116","author":"Richards","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.yjmcc.2011.02.013","article-title":"cGMP\/PKG pathway mediates myocardial postconditioning protection in rat hearts by delaying normalization of intracellular acidosis during reperfusion","volume":"50","author":"Inserte","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/HYPERTENSIONAHA.110.151324","article-title":"Decreased activity of the Na+\/H+ exchanger by phosphodiesterase 5A inhibition is attributed to an increase in protein phosphatase activity","volume":"56","author":"Yeves","year":"2010","journal-title":"Hypertension"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0003-4975(01)02823-5","article-title":"Effects of NHE-1 inhibition on cardioprotection and impact on protection by K\/Mg cardioplegia","volume":"72","author":"Toyoda","year":"2001","journal-title":"Ann. Thorac. Surg."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1007\/s00424-014-1682-0","article-title":"Murine cardiac growth, TRPC channels, and cGMP kinase I","volume":"467","author":"Domes","year":"2015","journal-title":"Pflug. Arch."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.pbiomolbio.2017.06.010","article-title":"Role of TRPC3 and TRPC6 channels in the myocardial response to stretch: Linking physiology and pathophysiology","volume":"130","author":"Yamaguchi","year":"2017","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"11363","DOI":"10.1073\/pnas.162100799","article-title":"Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes","volume":"99","author":"Fiedler","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.1073\/pnas.1001360107","article-title":"Cardiac hypertrophy is not amplified by deletion of cGMP-dependent protein kinase I in cardiomyocytes","volume":"107","author":"Lukowski","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"32831","DOI":"10.1074\/jbc.M603416200","article-title":"cGMP-dependent protein kinase type I inhibits TAB1-p38 mitogen-activated protein kinase apoptosis signaling in cardiac myocytes","volume":"281","author":"Fiedler","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41586-019-0895-y","article-title":"PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress","volume":"566","author":"Ranek","year":"2019","journal-title":"Nature"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cellsig.2016.02.019","article-title":"PKG-1\u03b1 mediates GATA4 transcriptional activity","volume":"28","author":"Ma","year":"2016","journal-title":"Cell Signal."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/01.CIR.102.11.1302","article-title":"Nitric oxide provokes tumor necrosis factor-alpha expression in adult feline myocardium through a cGMP-dependent pathway","volume":"102","author":"Kalra","year":"2000","journal-title":"Circulation"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1046\/j.1432-1033.2003.03574.x","article-title":"Phosphorylation of NF-kappaB proteins by cyclic GMP-dependent kinase. A noncanonical pathway to NF-kappaB activation","volume":"270","author":"He","year":"2003","journal-title":"Eur. J. Biochem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s12265-010-9195-5","article-title":"Dichotomous actions of NF-kappaB signaling pathways in heart","volume":"3","author":"Dhingra","year":"2010","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00392-010-0275-y","article-title":"Clinical correlates of endothelial function in chronic heart failure","volume":"100","author":"Ciccone","year":"2011","journal-title":"Clin. Res. Cardiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10741-018-9719-7","article-title":"Flow-mediated dilation and heart failure: A review with implications to physical rehabilitation","volume":"24","author":"Areas","year":"2019","journal-title":"Heart Fail. Rev."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/978-3-540-68964-5_19","article-title":"cGMP in the vasculature","volume":"191","author":"Schmidt","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41569-019-0227-9","article-title":"Vascular smooth muscle cells in atherosclerosis","volume":"16","author":"Basatemur","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","article-title":"Vascular Smooth Muscle Cells in Atherosclerosis","volume":"118","author":"Bennett","year":"2016","journal-title":"Circ. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/01.RES.0000017629.70769.CC","article-title":"Angiotensin II induces myocyte enhancer factor 2- and calcineurin\/nuclear factor of activated T cell-dependent transcriptional activation in vascular myocytes","volume":"90","author":"Suzuki","year":"2002","journal-title":"Circ. Res."},{"key":"ref_64","first-page":"L1","article-title":"Nitric oxide inhibits calcium release from sarcoplasmic reticulum of porcine tracheal smooth muscle cells","volume":"272","author":"Kannan","year":"1997","journal-title":"Am. J. Physiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"7485","DOI":"10.1523\/JNEUROSCI.22-17-07485.2002","article-title":"cGMP\/protein kinase G-dependent inhibition of N-type Ca2+ channels induced by nitric oxide in human neuroblastoma IMR32 cells","volume":"22","author":"Martinotti","year":"2002","journal-title":"J. Neurosci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s003950170018","article-title":"Intracellular mechanisms of cGMP-mediated regulation of myocardial contraction","volume":"96","author":"Satoh","year":"2001","journal-title":"Basic Res. Cardiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1745-7254.2005.00049.x","article-title":"Regulation of intracellular Ca2+ and calcineurin by NO\/PKG in proliferation of vascular smooth muscle cells","volume":"26","author":"Li","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1124\/mol.104.007724","article-title":"RGS2 is a mediator of nitric oxide action on blood pressure and vasoconstrictor signaling","volume":"67","author":"Sun","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/nm958","article-title":"Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure","volume":"9","author":"Tang","year":"2003","journal-title":"Nat. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1126\/science.286.5444.1583","article-title":"Regulation of myosin phosphatase by a specific interaction with cGMP- dependent protein kinase Ialpha","volume":"286","author":"Surks","year":"1999","journal-title":"Science"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"34496","DOI":"10.1074\/jbc.M405957200","article-title":"Smooth muscle phosphatase is regulated in vivo by exclusion of phosphorylation of threonine 696 of MYPT1 by phosphorylation of Serine 695 in response to cyclic nucleotides","volume":"279","author":"Wooldridge","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e007808","DOI":"10.1161\/JAHA.117.007808","article-title":"The Unexpected Role of Calcium-Activated Potassium Channels: Limitation of NO-Induced Arterial Relaxation","volume":"7","author":"Schmid","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/bs.apha.2016.07.001","article-title":"Potassium Channels in Regulation of Vascular Smooth Muscle Contraction and Growth","volume":"78","author":"Jackson","year":"2017","journal-title":"Adv. Pharmacol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"10927","DOI":"10.1074\/jbc.274.16.10927","article-title":"Cyclic GMP-dependent protein kinase activates cloned BKCa channels expressed in mammalian cells by direct phosphorylation at serine 1072","volume":"274","author":"Fukao","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/368850a0","article-title":"Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle","volume":"368","author":"Bolotina","year":"1994","journal-title":"Nature"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/sj.bjp.0701940","article-title":"Nitric oxide (NO)-induced activation of large conductance Ca2+-dependent K+ channels (BK(Ca)) in smooth muscle cells isolated from the rat mesenteric artery","volume":"124","author":"Mistry","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e13683","DOI":"10.1111\/acel.13683","article-title":"Soluble guanylate cyclase activator BAY 54-6544 improves vasomotor function and survival in an accelerated ageing mouse model","volume":"21","author":"Golshiri","year":"2022","journal-title":"Aging Cell."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10517-023-05703-7","article-title":"Anti-Atherosclerotic Action of a New Stimulator of Soluble Guanylate Cyclase in an Experiment","volume":"174","author":"Bykov","year":"2023","journal-title":"Bull. Exp. Biol. Med."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"da Silva, G.M., da Silva, M.C., Nascimento, D.V.G., Lima Silva, E.M., Gouv\u00eaa, F.F.F., de Fran\u00e7a Lopes, L.G., Ara\u00fajo, A.V., Ferraz Pereira, K.N., and de Queiroz, T.M. (2021). Nitric Oxide as a Central Molecule in Hypertension: Focus on the Vasorelaxant Activity of New Nitric Oxide Donors. Biology, 10.","DOI":"10.3390\/biology10101041"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"38","DOI":"10.18433\/jpps29578","article-title":"In Endothelial Cells, the Activation or Stimulation of Soluble Guanylyl Cyclase Induces the Nitric Oxide Production by a Mechanism Dependent of Nitric Oxide Synthase Activation","volume":"21","author":"Martinelli","year":"2018","journal-title":"J. Pharm. Pharm. Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.atherosclerosis.2023.03.017","article-title":"Stimulation of soluble guanylate cyclase activity with riociguat promotes angiogenesis and improves neovascularization after limb ischemia","volume":"372","author":"Dhahri","year":"2023","journal-title":"Atherosclerosis"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/FJC.0b013e3181eb4e75","article-title":"Heme-dependent and independent soluble guanylate cyclase activators and vasodilation","volume":"56","author":"Priviero","year":"2010","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1161\/ATVBAHA.109.192690","article-title":"Soluble guanylate cyclase agonists inhibit expression and procoagulant activity of tissue factor","volume":"29","author":"Sovershaev","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Mace, E.H., Kimlinger, M.J., Billings, F.T., and Lopez, M.G. (2023). Targeting Soluble Guanylyl Cyclase during Ischemia and Reperfusion. Cells, 12.","DOI":"10.3390\/cells12141903"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Nickel, K.F., Laux, V., Heumann, R., and von Degenfeld, G. (2013). Thrombin has biphasic effects on the nitric oxide-cGMP pathway in endothelial cells and contributes to experimental pulmonary hypertension. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0063504"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.redox.2017.08.020","article-title":"Identification of a soluble guanylate cyclase in RBCs: Preserved activity in patients with coronary artery disease","volume":"14","author":"Mergia","year":"2018","journal-title":"Redox Biol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jacbts.2023.02.017","article-title":"Stimulation of Erythrocyte Soluble Guanylyl Cyclase Induces cGMP Export and Cardioprotection in Type 2 Diabetes","volume":"8","author":"Jiao","year":"2023","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e167693","DOI":"10.1172\/JCI167693","article-title":"Hypoxic erythrocytes mediate cardioprotection through activation of soluble guanylate cyclase and release of cyclic GMP","volume":"133","author":"Yang","year":"2023","journal-title":"J. Clin. Investig."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1600-0773.1992.tb00985.x","article-title":"Exogenous GTP increases cyclic GMP and inhibits thrombin-induced aggregation of washed human platelets: Comparison with ATP, adenosine and guanosine","volume":"71","author":"Vuorinen","year":"1992","journal-title":"Pharmacol. Toxicol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1160\/TH11-05-0319","article-title":"Differentiation of cGMP-dependent and -independent nitric oxide effects on platelet apoptosis and reactive oxygen species production using platelets lacking soluble guanylyl cyclase","volume":"106","author":"Rukoyatkina","year":"2011","journal-title":"Thromb. Haemost."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/s44161-022-00175-w","article-title":"Loss of soluble guanylyl cyclase in platelets contributes to atherosclerotic plaque formation and vascular inflammation","volume":"1","author":"Mauersberger","year":"2022","journal-title":"Nat. Cardiovasc. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/5584_2017_126","article-title":"Heart Failure and Kidney Disease","volume":"1067","author":"Grande","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","article-title":"Renal impairment, worsening renal function, and outcome in patients with heart failure: An updated meta-analysis","volume":"35","author":"Damman","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Krishnan, S.M., Kraehling, J.R., Eitner, F., B\u00e9nardeau, A., and Sandner, P. (2018). The Impact of the Nitric Oxide (NO)\/Soluble Guanylyl Cyclase (sGC) Signaling Cascade on Kidney Health and Disease: A Preclinical Perspective. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19061712"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1681\/ASN.V12112209","article-title":"Cellular distribution and function of soluble guanylyl cyclase in rat kidney and liver","volume":"12","author":"Theilig","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1111\/bph.15586","article-title":"Novel soluble guanylyl cyclase activators increase glomerular cGMP, induce vasodilation and improve blood flow in the murine kidney","volume":"179","author":"Stehle","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"F193","DOI":"10.1152\/ajprenal.00272.2020","article-title":"Role of soluble guanylyl cyclase in renal afferent and efferent arterioles","volume":"320","author":"Wennysia","year":"2021","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"F1003","DOI":"10.1152\/ajprenal.00229.2014","article-title":"Role of soluble guanylate cyclase in renal hemodynamics and autoregulation in the rat","volume":"307","author":"Dautzenberg","year":"2014","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"\u2019t Hart, D., Li, J., van der Vlag, J., and Nijenhuis, T. (2021). Repurposing Riociguat to Target a Novel Paracrine Nitric Oxide-TRPC6 Pathway to Prevent Podocyte Injury. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222212485"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"121460","DOI":"10.1016\/j.lfs.2023.121460","article-title":"Soluble guanylate cyclase agonist, isoliquiritigenin attenuates renal damage and aortic calcification in a rat model of chronic kidney failure","volume":"317","author":"Atteia","year":"2023","journal-title":"Life Sci."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Braun, D., Zollbrecht, C., Dietze, S., Schubert, R., Golz, S., Summer, H., Persson, P.B., Carlstr\u00f6m, M., Ludwig, M., and Patzak, A. (2018). Hypoxia\/Reoxygenation of Rat Renal Arteries Impairs Vasorelaxation via Modulation of Endothelium-Independent sGC\/cGMP\/PKG Signaling. Front. Physiol., 9.","DOI":"10.3389\/fphys.2018.00480"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1111\/bph.15425","article-title":"Activation of soluble guanylyl cyclase signalling with cinaciguat improves impaired kidney function in diabetic mice","volume":"179","author":"Harloff","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1016\/j.ajpath.2014.06.014","article-title":"Thrombospondin-1 deficiency causes a shift from fibroproliferative to inflammatory kidney disease and delays onset of renal failure","volume":"184","author":"Zeisberg","year":"2014","journal-title":"Am. J. Pathol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/sj.bjp.0706792","article-title":"NO-independent activation of soluble guanylate cyclase prevents disease progression in rats with 5\/6 nephrectomy","volume":"148","author":"Kalk","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/2211-5463.12202","article-title":"Inhibition of the TGF\u03b2 signalling pathway by cGMP and cGMP-dependent kinase I in renal fibrosis","volume":"7","author":"Schinner","year":"2017","journal-title":"FEBS Open Bio"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"F148","DOI":"10.1152\/ajprenal.00247.2019","article-title":"Soluble guanylate cyclase stimulator praliciguat attenuates inflammation, fibrosis, and end-organ damage in the Dahl model of cardiorenal failure","volume":"318","author":"Shea","year":"2020","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"F474","DOI":"10.1152\/ajprenal.2001.280.3.F474","article-title":"NO\/cGMP signaling modulates regulation of Na+-K+-ATPase activity by angiotensin II in rat proximal tubules","volume":"280","author":"Zhang","year":"2001","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1681\/ASN.2013060596","article-title":"Angiotensin II dose-dependently stimulates human renal proximal tubule transport by the nitric oxide\/guanosine 3\u2032,5\u2032-cyclic monophosphate pathway","volume":"25","author":"Shirai","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"F411","DOI":"10.1152\/ajprenal.00014.2004","article-title":"Regulation of an inwardly rectifying K+ channel by nitric oxide in cultured human proximal tubule cells","volume":"287","author":"Nakamura","year":"2004","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_110","first-page":"479","article-title":"Role of inwardly rectifying K+ channel 5.1 (Kir5.1) in the regulation of renal membrane transport","volume":"31","author":"Lin","year":"2022","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1042\/BJ20051455","article-title":"Involvement of the Gi\/o\/cGMP\/PKG pathway in the AT2-mediated inhibition of outer cortex proximal tubule Na+-ATPase by Ang-(1-7)","volume":"395","author":"Cavalcante","year":"2006","journal-title":"Biochem. J."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1097\/HJH.0b013e3283532099","article-title":"Angiotensin II AT2 receptor decreases AT1 receptor expression and function via nitric oxide\/cGMP\/Sp1 in renal proximal tubule cells from Wistar-Kyoto rats","volume":"30","author":"Yang","year":"2012","journal-title":"J. Hypertens."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Newaz, M.A., Ranganna, K., and Oyekan, A.O. (2004). Relationship between PPARalpha activation and NO on proximal tubular Na+ transport in the rat. BMC Pharmacol., 4.","DOI":"10.1186\/1471-2210-4-1"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"F697","DOI":"10.1152\/ajprenal.00003.2020","article-title":"Praliciguat inhibits progression of diabetic nephropathy in ZSF1 rats and suppresses inflammation and apoptosis in human renal proximal tubular cells","volume":"319","author":"Liu","year":"2020","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/01.HYP.27.3.679","article-title":"Mechanism of the nitric oxide-induced blockade of collecting duct water permeability","volume":"27","author":"Garcia","year":"1996","journal-title":"Hypertension"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Wagner, K., Unger, L., Salman, M.M., Kitchen, P., Bill, R.M., and Yool, A.J. (2022). Signaling Mechanisms and Pharmacological Modulators Governing Diverse Aquaporin Functions in Human Health and Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031388"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Noda, Y., and Sasaki, S. (2021). Updates and Perspectives on Aquaporin-2 and Water Balance Disorders. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222312950"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"F693","DOI":"10.1152\/ajprenal.00136.2009","article-title":"Atrial natriuretic peptide and nitric oxide signaling antagonizes vasopressin-mediated water permeability in inner medullary collecting duct cells","volume":"297","author":"Klokkers","year":"2009","journal-title":"Am. J. Physiol. Ren. Physiol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/10\/4550\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:30:12Z","timestamp":1760031012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/10\/4550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":118,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["ijms26104550"],"URL":"https:\/\/doi.org\/10.3390\/ijms26104550","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]}}}